CAS No. |
98665-15-7 |
中文名称 |
(6R)-6-((5R,10S,12S,13R,14R,17R)-12-乙酰氧基-4,4,10,13,14-五甲基-3,7,11,15-四氧代-2,3,4,5,6,7,10,11,12,13,14,15,16,17-十四氢-1H-环戊并[a]菲基-17-基)-2-甲基-4-氧代庚酸 |
英文名称 |
(6R)-6-((5R,10S,12S,13R,14R,17R)-12-Acetoxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid |
别名 |
12β)-12-(Acetyloxy)-3,7,11,15,23-pentaoxolanost-8-en-26-oic acid | (6R)-6-((5R,10S,12S,13R,14R,17R)-12-Acetoxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxo |
标准英文名 |
(6R)-6-((5R,10S,12S,13R,14R,17R)-12-acetoxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid |
MDL No. |
MFCD09264655 |
分子式 |
C32H42O9 |
分子量 |
570.68
|
精确分子量 |
570.28
|
SMILES |
CC(=O)O[C@@H]1C(=O)C2=C(C(=O)C[C@H]3C(C)(C)C(=O)CC[C@]23C)[C@]2(C)C(=O)C[C@H]([C@H](C)CC(=O)CC(C)C(=O)O)[C@@]12C |
标准SMILES |
CC1(C)[C@@H]2CC(=O)C3=C(C(=O)[C@@H](OC(C)=O)[C@]4(C)[C@H](CC(=O)[C@]43C)[C@H](C)CC(=O)CC(C)C(O)=O)[C@@]2(C)CCC1=O |
用途 |
Ganoderic acid F exhibits antitumor and antimetastatic activities by inhibiting angiogenesis and modulating proteins involved in cell proliferation and/or cell death, carcinogenesis, oxidative stress, calcium signaling, and endoplasmic reticulum stress; it inhibits the proliferation of HeLa human cervical carcinoma cells in vitro (IC₅₀ = 19.5 μM at 48 hours); it also possesses hypolipidemic and antihypertensive effects. |
InChIKey |
BWCNWXLKMWWVBT-AIMUVTGPSA-N |